MedTrace Logo

Diphtheria Vaccination in Adolescents With Inflammatory Bowel Disease

NCT03998215 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2019-06-26

No results posted yet for this study

Summary

Assessment of the immunogenicity and safety of booster immunization against diphtheria in children with inflammatory bowel disease.

Conditions

  • Diphtheria
  • Inflammatory Bowel Diseases

Interventions

BIOLOGICAL

Diphtheria booster vaccination

Participants received intramuscularly in the deltoid muscle one dose of the trivalent vaccine against diphtheria, tetanus and acellular pertussis

Sponsors & Collaborators

  • Wroclaw Medical University

    collaborator OTHER

  • Poznan University of Medical Sciences

    collaborator OTHER

  • Medical University of Silesia

    collaborator OTHER

  • Medical University of Warsaw

    lead OTHER

Principal Investigators

  • Aleksandra Banaszkiewicz, MD, PhD · Medical University of Warsaw

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
11 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-12-01
Primary Completion
2015-01-01
Completion
2015-01-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03998215 on ClinicalTrials.gov